Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
7 Healthcare Stocks to Make You the Millionaire Next Door
08:41pm, Wednesday, 21'st Jun 2023
Investing in healthcare stocks can be a wise decision for those looking to become wealthy in the long term. Some of the best healthcare stocks to buy are firms that are developing highly effective dr
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults over 60
05:57pm, Wednesday, 21'st Jun 2023
The CDC panel's recommendation moves the U.S. closer to making the respiratory syncytial virus shots from Pfizer and GSK available to seniors.
GSK's RSV Vaccine Could Be Effective for Longer. What That Means.
02:38pm, Wednesday, 21'st Jun 2023
The drugmaker says its RSV shot prevents disease for 18 months.
GSK says RSV vaccine for older adults provides protection over two seasons
10:38am, Wednesday, 21'st Jun 2023
GlaxoSmithKline's new clinical trial results suggest seniors may only need to take the pharmaceutical company's RSV shot every other year.
RSV vaccine for older adults provides protection over two seasons, GSK says
08:40am, Wednesday, 21'st Jun 2023
GSK's GSK, -1.51% respiratory syncytial virus vaccine for older adults may protect against disease for two full RSV seasons, according to new results from a phase 3 trial the company released Wednesda
US CDC advisers weigh use of GSK, Pfizer RSV vaccines in older adults
06:07am, Wednesday, 21'st Jun 2023
A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday will vote on whether to recommend the use of recently approved vaccines from Pfizer and GSK to prevent sev
RSV Vaccine For Adults Gives Long-Term Protection, GSK Says After Late-Stage Trial
06:06am, Wednesday, 21'st Jun 2023
GSK said its shot, the world's first authorized RSV vaccine, showed protection in older adults for two seasons after a single dose.
GSK: Does new RSV jab have the edge of Pfizer's vaccine?
03:13am, Wednesday, 21'st Jun 2023
GSK PLC (LSE:GSK, NYSE:GSK)'s respiratory syncytial virus (RSV) vaccine, Arexvy, demonstrated robust long-term protection in a late-stage trial, targeting older adults, the pharma giant revealed on We
GSK's RSV vaccine shows long-term efficacy in late-stage trial
02:31am, Wednesday, 21'st Jun 2023
GSK on Wednesday said its vaccine for the respiratory syncytial virus (RSV), which recently won EU approval, showed strong long-term protection in older adults in a late-stage trial.
GSK vs. TECH: Which Stock Should Value Investors Buy Now?
01:16pm, Tuesday, 20'th Jun 2023
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either GSK (GSK) or Techne (TECH). But which of these two stocks presents investors with the better
GSK Announces Extension of FDA Review for Rare Blood Therapy
11:43am, Monday, 19'th Jun 2023
GSK announces the FDA's extension of the review period of its new drug application for momelotinib to treat myelofibrosis by three months. A decision is now expected on Sep 16, 2023.
Bellus Health shareholders say yes to US$2B GSK takeover
10:04am, Monday, 19'th Jun 2023
BELLUS Health Inc (TSX:BLU) said its shareholders overwhelmingly have approved a US$2 billion takeover by GSK PLC (LSE:GSK, NYSE:GSK). The late-stage biopharmaceutical firm said in a statement that al
2 Top Healthcare Stocks to Buy Right Now
09:15am, Friday, 16'th Jun 2023
A growing and aging population bodes well for companies in the healthcare industry. GSK is a long-established drugmaker that is still innovating and developing promising products.
GSK delay for new drug with US regulator 'not necessarily a red flag' - analyst
08:11am, Friday, 16'th Jun 2023
A regulatory delay for GSK PLC (LSE:GSK, NYSE:GSK) with the 'centrepiece' drug of its US$2bn Sierra Oncology (NASDAQ:SRRA) acquisition last year "isn't necessarily a red flag", according to an anal
GSK says FDA extends review period for experimental drug momelotinib
02:29am, Friday, 16'th Jun 2023
British drugmaker GSK Plc on Friday said the U.S. Food and Drug Administration has extended the review period for its experimental drug momelotinib, which is designed to treat anaemic patients with a
